Multiple sclerosis |
Cox et al. |
2012 |
726 |
604 |
TaqI, FokI |
Only weak association between TaqI and MS. |
[48] |
Sioka et al. |
2011 |
69 |
81 |
BsmI, TaqI |
No. |
[47] |
Simon et al. |
2010 |
214 |
428 |
ApaI, BsmI, TaqI, FokI, Cdx2 |
No. But dietary intake of vitamin D was inversely related to MS risk in only the MS patients with the FokI ff genotype. |
[35] |
Smolders et al. |
2009 |
212 |
289 |
ApaI, TaqI |
No. |
[45] |
Smolders et al. |
2009 |
212 |
289 |
FokI |
No. But the F allele was associated with lower serum 25(OH)D levels in both MS patients and controls. However, the F-allele corresponded with higher 1,25 (OH)2D levels in MS patients. |
[22] |
Tajouri et al. |
2005 |
104 |
104 |
ApaI, TaqI, FokI |
Yes. Only the frequency of the TaqI allele/genotype and the ApaI allele was different between MS patients and controls. |
[34] |
Niino et al. |
2000 |
77 |
95 |
ApaI |
Yes. The ApaI A allele/AA genotype were more prevalent in MS patients than in controls. |
[39] |
Fukazawa et al. |
1999 |
77 |
95 |
BsmI |
Yes. The BsmI b allele/bb genotype were more prevalent in MS patients than in controls. |
[36] |
Type 1 diabetes mellitus |
Mohammadnejad et al. |
2012 |
87 |
100 |
ApaI, BsmI, TaqI, FokI |
Yes. Only the frequency of the TaqI T allele/TT genotype was higher in controls compared to T1DM patients. |
[32] |
Gogas Yavuz et al. |
2011 |
117 |
134 |
ApaI, BsmI, TaqI, FokI |
No. |
[31] |
Panierakis et al. |
2009 |
100 |
96 |
ApaI, BsmI, TaqI, FokI |
Yes. The ApaI A allele/AA genotype and the TaqI T allele/TT genotype were more frequent in T1DM patients, whereas the BsmI B allele/BB genotype and the FokI F allele/FF genotype were less frequent in T1DM. |
[30] |
Shimada et al. |
2008 |
774 |
599 |
BsmI |
Yes. The BB genotype frequency was significantly higher in T1DM patients compared to controls. |
[42] |
Lemos et al. |
2008 |
207 |
249 |
ApaI, BsmI, TaqI, FokI |
No. |
[29] |
Capoluongo et al. |
2006 |
246 |
246 |
BsmI, FokI |
Yes. Only the frequency of the FokI ff genotype was higher in TIDM patients compared to controls. |
[28] |
Audi et al. |
2004 |
89 |
116 |
BsmI, FokI |
Yes. The frequency of the FokI ff genotype was lower in T1DM patients compared to controls. |
[27] |
Gyorffy et al. |
2002 |
107 |
103 |
ApaI, BsmI, FokI, Tru9I |
No. |
[26] |
Fassbender et al. |
2002 |
75 |
57 |
BsmI, TaqI, FokI |
Yes. Only the frequency of the TaqI TT genotype was higher in T1DM patients than in controls. |
[25] |
Taverna et al. |
2002 |
101 |
99 |
TaqI |
Yes. The frequency of the TT genotype was lower in T1DM patients compared to controls. |
[41] |
Ban et al. |
2001 |
110 |
250 |
Fok I |
Yes. There was a higher prevalence of the F allele/FF genotype in T1DM patients compared to controls. |
[24] |
Chang et al. |
2000 |
157 |
248 |
ApaI, BsmI, TaqI |
Yes. Only the allelic frequency of the BsmI B allele was higher in T1DM patients than in controls. |
[37] |
Systemic lupus erythematosus |
Luo et al. |
2012 |
337 |
239 |
BsmI |
Yes. The alleic frequency of the B allele, but not the frequency of the BB genotype, was higher in SLE patients compared to controls. |
[43] |
Monticielo et al. |
2012 |
195 |
201 |
BsmI, FokI |
No. But 25(OH)D concentrations were significantly higher in SLE patients carrying the FokI ff genotype compared with patients carrying the FF genotype. |
[23] |
Abbasi et al. |
2010 |
60 |
45 |
BsmI |
No. |
[46] |
Sakulpipatsin et al. |
2006 |
101 |
194 |
BsmI |
No. |
[44] |
Huang et al. |
2002 |
52 |
90 |
FokI |
No. |
[33] |
Huang et al. |
2002 |
47 |
90 |
BsmI |
Yes. The distribution of the B allele/BB genotype was increased in SLE patients. |
[40] |
Ozaki et al. |
2000 |
58 |
87 |
BsmI |
Yes. The frequency of the BB genotype was significantly higher in SLE patients than in controls. |
[38] |